Programmable removal of bacterial strains by use of genome- targeting CRISPR-cas systems

mBio

Volumn 5, Issue 1, 2014, Pages

  Gomaa, Ahmed A ^a   Klumpe, Heidi E ^a   Luo, Michelle L ^a   Selle, Kurt ^b   Barrangou, Rodolphe ^b   Beisel, Chase L ^a  

^a North Carolina State University   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM CULTURE; CAS GENE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; ESCHERICHIA COLI; FTSA GENE; GENE EXPRESSION; GENE TARGETING; GENOME ANALYSIS; MULTIDRUG RESISTANCE; NONHUMAN; OPERON; POINT MUTATION; PRIORITY JOURNAL; RNA CLEAVAGE; RNA DEGRADATION; RNA PROCESSING;

CRISPR-CAS SYSTEMS; DNA, BACTERIAL; ESCHERICHIA COLI; GENOME, BACTERIAL; HYDROLYSIS; MICROBIAL VIABILITY;

EID: 84903362877     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00928-13     Document Type: Article

References (58)

1. Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ. 2008. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 104:1-13. http:// dx.doi.org/10.1111/j.1365-2672.2007.03498.x.
2. Koskella B, Meaden S. 2013. Understanding bacteriophage specificity in natural microbial communities. Viruses 5:806-823. http://dx.doi.org/ 10.3390/v5030806.
3. Sorek R, Lawrence CM, Wiedenheft B. 2013. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu. Rev. Biochem. 82: 237-266. http://dx.doi.org/10.1146/annurev-biochem-072911-172315.
4. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-1712. http://dx.doi.org/ 10.1126/science.1138140.
5. Garneau JE, Dupuis MÈ, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S. 2010. The CRISPR/ Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67-71. http://dx.doi.org/10.1038/nature09523.
6. Sinkunas T, Gasiunas G, Waghmare SP, Dickman MJ, Barrangou R, Horvath P, Siksnys V. 2013. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 32:385-394. http://dx.doi.org/10.1038/emboj.2012.352.
7. Gasiunas G, Barrangou R, Horvath P, Siksnys V. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109:E2579-E2586. http://dx.doi.org/10.1073/pnas.1208507109.
8. Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, Moineau S, Mojica FJ, Wolf YI, Yakunin AF, van der Oost J, Koonin EV. 2011. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9:467-477. http://dx.doi.org/10.1038/ nrmicro2577.
9. Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, van der Oost J, Brouns SJ, Severinov K. 2011. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. U. S. A. 108: 10098-10103. http://dx.doi.org/10.1073/pnas.1104144108.
10. Mojica FJ, Díez-Villaseñor C, García-Martínez J, Almendros C. 2009. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155:733-740. http://dx.doi.org/10.1099/ mic.0.023960-0.
11. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31:233-239. http://dx.doi.org/10.1038/nbt.2508.
12. Wiedenheft B, van Duijn E, Bultema JB, Bultema J, Waghmare SP, Waghmare S, Zhou K, Barendregt A, Westphal W, Heck AJ, Heck A, Boekema EJ, Boekema E, Dickman MJ, Dickman M, Doudna JA. 2011. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc. Natl. Acad. Sci. U. S. A. 108:10092-10097. http://dx.doi.org/10.1073/pnas.1102716108.
13. Marraffini LA, Sontheimer EJ. 2010. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463:568-571. http:// dx.doi.org/10.1038/nature08703.
14. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339:823-826. http://dx.doi.org/10.1126/science.1232033.
15. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823. http://dx.doi.org/ 10.1126/science.1231143.
16. Stern A, Keren L, Wurtzel O, Amitai G, Sorek R. 2010. Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genet. 26:335-340. http://dx.doi.org/10.1016/j.tig.2010.05.008.
17. Aklujkar M, Lovley DR. 2010. Interference with histidyl-tRNA synthetase by a CRISPR spacer sequence as a factor in the evolution of Pelobacter carbinolicus. BMC Evol. Biol. 10:230. http://dx.doi.org/10.1186/1471-2148-10-230.
18. Paez-Espino D, Morovic W, Sun CL, Thomas BC, Ueda K, Stahl B, Barrangou R, Banfield JF. 2013. Strong bias in the bacterial CRISPR elements that confer immunity to phage. Nat. Commun 4:1430. http:// dx.doi.org/10.1038/ncomms2440.
19. Manica A, Zebec Z, Teichmann D, Schleper C. 2011. In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon. Mol. Microbiol. 80:481-491. http://dx.doi.org/10.1111/j.1365-2958.2011.07586.x.
20. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173-1183. http:// dx.doi.org/10.1016/j.cell.2013.02.022.
21. Edgar R, Qimron U. 2010. The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction. J. Bacteriol. 192:6291-6294. http://dx.doi.org/10.1128/JB.00644-10.
22. Yosef I, Goren MG, Kiro R, Edgar R, Qimron U. 2011. Hightemperature protein G is essential for activity of the Escherichia coli clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system. Proc. Natl. Acad. Sci. U. S. A. 108:20136-20141. http://dx.doi.org/ 10.1073/pnas.1113519108.
23. Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. 2013. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41: 7429-7437. http://dx.doi.org/10.1093/nar/gkt520.
24. Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA. 2012. CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12:177-186. http:// dx.doi.org/10.1016/j.chom.2012.06.003.
25. Vercoe RB, Chang JT, Dy RL, Taylor C, Gristwood T, Clulow JS, Richter C, Przybilski R, Pitman AR, Fineran PC. 2013. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLOS Genet. 9 e1003454. http://dx.doi.org/10.1371/journal.pgen.1003454.
26. Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. 2008. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960-964. http://dx.doi.org/10.1126/science.1159689.
27. Pul U, Wurm R, Arslan Z, Geissen R, Hofmann N, Wagner R. 2010. Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS. Mol. Microbiol. 75:1495-1512. http://dx.doi.org/ 10.1111/j.1365-2958.2010.07073.x.
28. Jiang W, Maniv I, Arain F, Wang Y, Levin BR, Marraffini LA. 2013. Dealing with the evolutionary downside of CRISPR Immunity: bacteria and beneficial plasmids. PLoS Genet. 9:e1003844. http://dx.doi.org/ 10.1371/journal.pgen.1003844.
29. Karvelis T, Gasiunas G, Miksys A, Barrangou R, Horvath P, Siksnys V. 2013. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus. RNA Biol. 10:841-851. http://dx.doi.org/ 10.4161/rna.24203.
30. Studier FW, Daegelen P, Lenski RE, Maslov S, Kim JF. 2009. Understanding the differences between genome sequences of Escherichia coli B strains REL606 and BL21(DE3) and comparison of the E. coli B and K-12 genomes. J. Mol. Biol. 394:653-680. http://dx.doi.org/10.1016/ j.jmb.2009.09.021.
31. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856. http://dx.doi.org/10.1038/35101614.
32. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-821. http://dx.doi.org/10.1126/ science.1225829.
33. Sinkunas T, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V. 2011. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J. 30:1335-1342. http://dx.doi.org/10.1038/emboj.2011.41.
34. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. 2013. High-throughput profiling of off-target DNA cleavage reveals RNAprogrammed Cas9 nuclease specificity. Nat. Biotechnol. 31:839-843. http://dx.doi.org/10.1038/nbt.2673.
35. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F. 2013. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31:827-832. http://dx.doi.org/10.1038/nbt.2647.
36. Cradick TJ, Fine EJ, Antico CJ, Bao G. 2013. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 41:9584-9592. http://dx.doi.org/10.1093/nar/gkt714.
37. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31:822-826. http://dx.doi.org/ 10.1038/nbt.2623.
38. Fraley RT, Fornari CS, Kaplan S. 1979. Entrapment of a bacterial plasmid in phospholipid vesicles: potential for gene transfer. Proc. Natl. Acad. Sci. U. S. A. 76:3348-3352. http://dx.doi.org/10.1073/pnas.76.7.3348.
39. Lu TK, Collins JJ. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl. Acad. Sci. U. S. A. 104:11197-11202. http:// dx.doi.org/10.1073/pnas.0704624104.
40. Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, Norris JS. 2003. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob. Agents Chemother. 47: 1301-1307. http://dx.doi.org/10.1128/AAC.47.4.1301-1307.2003.
41. Kaiser D, Dworkin M. 1975. Gene transfer to myxobacterium by Escherichia coli phage P1. Science 187:653-654. http://dx.doi.org/10.1126/ science.803710.
42. Hagens S, Habel A, von Ahsen U, von Gabain A, Bläsi U. 2004. Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. 48:3817-3822. http:// dx.doi.org/10.1128/AAC.48.10.3817-3822.2004.
43. Westwater C, Schofield DA, Schmidt MG, Norris JS, Dolan JW. 2002. Development of a P1 phagemid system for the delivery ofDNAinto gramnegative bacteria. Microbiology (Reading, Engl.) 148:943-950.
44. Rai M, Yadav A, Gade A. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27:76-83. http://dx.doi.org/10.1016/ j.biotechadv.2008.09.002.
45. Lu TK, Koeris MS. 2011. The next generation of bacteriophage therapy. Curr. Opin. Microbiol. 14:524-531. http://dx.doi.org/10.1016/ j.mib.2011.07.028.
46. Sapranauskas R, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V. 2011. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 39:9275-9282. http://dx.doi.org/10.1093/nar/gkr606.
47. Qi L, Haurwitz RE, Shao W, Doudna JA, Arkin AP. 2012. RNA processing enables predictable programming of gene expression. Nat. Biotechnol. 30:1002-1006. http://dx.doi.org/10.1038/nbt.2355.
48. Ebina H, Misawa N, Kanemura Y, Koyanagi Y. 2013. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci. Rep. 3:2510. http://dx.doi.org/10.1038/srep02510.
49. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
50. Swingle B, Markel E, Costantino N, Bubunenko MG, Cartinhour S, Court DL. 2010. Oligonucleotide recombination in gram-negative bacteria. Mol. Microbiol. 75:138-148. http://dx.doi.org/10.1111/j.1365-2958.2009.06976.x.
51. Wang HH, Xu G, Vonner AJ, Church G. 2011. Modified bases enable high-efficiency oligonucleotide-mediated allelic replacement via mismatch repair evasion. Nucleic Acids Res. 39:7336-7347. http://dx.doi.org/ 10.1093/nar/gkr183.
52. Olsen PA, Randøl M, Luna L, Brown T, Krauss S. 2005. Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends. J. Gene Med. 7:1534-1544. http://dx.doi.org/10.1002/jgm.804.
53. Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121-4130.
54. Gibson DG. 2011. Enzymatic assembly of overlapping DNA fragments. Methods Enzymol. 498:349-361. http://dx.doi.org/10.1016/B978-0-12-385120-8.00015-2.
55. Russell WM, Klaenhammer TR. 2001. Efficient system for directed integration into the Lactobacillus acidophilus and Lactobacillus gasseri chromosomes via homologous recombination. Appl. Environ. Microbiol. 67: 4361-4364. http://dx.doi.org/10.1128/AEM.67.9.4361-4364.2001.
56. Makarova K, Slesarev A, Wolf Y, Sorokin A, Mirkin B, Koonin E, Pavlov A, Pavlova N, Karamychev V, Polouchine N, Shakhova V, Grigoriev I, Lou Y, Rohksar D, Lucas S, Huang K, Goodstein DM, Hawkins T, Plengvidhya V, Welker D, Hughes J, Goh Y, Benson A, Baldwin K, Lee JH, Díaz-Muñiz I, Dosti B, Smeianov V, Wechter W, Barabote R, Lorca G, Altermann E, Barrangou R, Ganesan B, Xie Y, Rawsthorne H, Tamir D, Parker C, Breidt F, Broadbent J, Hutkins R, O'Sullivan D, Steele J, Unlu G, Saier M, Klaenhammer T, Richardson P, Kozyavkin S, Weimer B, Mills D. 2006. Comparative genomics of the lactic acid bacteria. Proc. Natl. Acad. Sci. U. S. A. 103:15611-15616. http:// dx.doi.org/10.1073/pnas.0607117103.
57. Walker DC, Aoyama K, Klaenhammer TR. 1996. Electrotransformation of lactobacillus acidophilus group A1. FEMS Microbiol. Lett. 138:233-237. http://dx.doi.org/10.1111/j.1574-6968.1996.tb08163.x.
58. Lambrecht JA, Schmitz GE, Downs DM. 2013. RidA proteins prevent metabolic damage inflicted by PLP-dependent dehydratases in all domains of life. mBio 4(1):e00033-13. http://dx.doi.org/10.1128/ mBio.00033-13.